These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 18092194

  • 1. Results of a population-based screening for hereditary breast cancer in a region of North-Central Italy: contribution of BRCA1/2 germ-line mutations.
    Seymour IJ, Casadei S, Zampiga V, Rosato S, Danesi R, Scarpi E, Falcini F, Strada M, Morini N, Naldoni C, Amadori D, Calistri D.
    Breast Cancer Res Treat; 2008 Nov; 112(2):343-9. PubMed ID: 18092194
    [Abstract] [Full Text] [Related]

  • 2. BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in Italy.
    Ottini L, Masala G, D'Amico C, Mancini B, Saieva C, Aceto G, Gestri D, Vezzosi V, Falchetti M, De Marco M, Paglierani M, Cama A, Bianchi S, Mariani-Costantini R, Palli D.
    Cancer Res; 2003 Jan 15; 63(2):342-7. PubMed ID: 12543786
    [Abstract] [Full Text] [Related]

  • 3. Mutation analysis of BRIP1/BACH1 in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives.
    Cao AY, Huang J, Hu Z, Li WF, Ma ZL, Tang LL, Zhang B, Su FX, Zhou J, Di GH, Shen KW, Wu J, Lu JS, Luo JM, Yuan WT, Shen ZZ, Huang W, Shao ZM.
    Breast Cancer Res Treat; 2009 May 15; 115(1):51-5. PubMed ID: 18483852
    [Abstract] [Full Text] [Related]

  • 4. Contribution of BRCA1 and BRCA2 germ-line mutations to the incidence of breast cancer in young women: results from a prospective population-based study in France.
    Bonadona V, Sinilnikova OM, Chopin S, Antoniou AC, Mignotte H, Mathevet P, Brémond A, Martin A, Bobin JY, Romestaing P, Raudrant D, Rudigoz RC, Léoné M, Chauvin F, Easton DF, Lenoir GM, Lasset C.
    Genes Chromosomes Cancer; 2005 Aug 15; 43(4):404-13. PubMed ID: 15887246
    [Abstract] [Full Text] [Related]

  • 5. Founder mutations account for the majority of BRCA1-attributable hereditary breast/ovarian cancer cases in a population from Tuscany, Central Italy.
    Papi L, Putignano AL, Congregati C, Zanna I, Sera F, Morrone D, Falchetti M, Turco MR, Ottini L, Palli D, Genuardi M.
    Breast Cancer Res Treat; 2009 Oct 15; 117(3):497-504. PubMed ID: 18821011
    [Abstract] [Full Text] [Related]

  • 6. Incidence of BRCA1 and BRCA2 mutations in 54 Chilean families with breast/ovarian cancer, genotype-phenotype correlations.
    Gallardo M, Silva A, Rubio L, Alvarez C, Torrealba C, Salinas M, Tapia T, Faundez P, Palma L, Riccio ME, Paredes H, Rodriguez M, Cruz A, Rousseau C, King MC, Camus M, Alvarez M, Carvallo P.
    Breast Cancer Res Treat; 2006 Jan 15; 95(1):81-7. PubMed ID: 16261400
    [Abstract] [Full Text] [Related]

  • 7. Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada.
    Risch HA, McLaughlin JR, Cole DE, Rosen B, Bradley L, Fan I, Tang J, Li S, Zhang S, Shaw PA, Narod SA.
    J Natl Cancer Inst; 2006 Dec 06; 98(23):1694-706. PubMed ID: 17148771
    [Abstract] [Full Text] [Related]

  • 8. BRCA1 mutations and polymorphisms in a hospital-based consecutive series of breast cancer patients from Apulia, Italy.
    Tommasi S, Crapolicchio A, Lacalamita R, Bruno M, Monaco A, Petroni S, Schittulli F, Longo S, Digennaro M, Calistri D, Mangia A, Paradiso A.
    Mutat Res; 2005 Oct 15; 578(1-2):395-405. PubMed ID: 16026807
    [Abstract] [Full Text] [Related]

  • 9. Ashkenazi founder BRCA1/BRCA2 mutations in Slovak hereditary breast and/or ovarian cancer families.
    Cierniková S, Tomka M, Kovác M, Stevurková V, Zajac V.
    Neoplasma; 2006 Oct 15; 53(2):97-102. PubMed ID: 16575464
    [Abstract] [Full Text] [Related]

  • 10. BRCA1 and BRCA2 mutation prevalence and clinical characteristics of a population-based series of ovarian cancer cases from Denmark.
    Soegaard M, Kjaer SK, Cox M, Wozniak E, Høgdall E, Høgdall C, Blaakaer J, Jacobs IJ, Gayther SA, Ramus SJ.
    Clin Cancer Res; 2008 Jun 15; 14(12):3761-7. PubMed ID: 18559594
    [Abstract] [Full Text] [Related]

  • 11. BRCA1 and BRCA2 mutations in Danish families with hereditary breast and/or ovarian cancer.
    Thomassen M, Hansen TV, Borg A, Lianee HT, Wikman F, Pedersen IS, Bisgaard ML, Nielsen FC, Kruse TA, Gerdes AM.
    Acta Oncol; 2008 Jun 15; 47(4):772-7. PubMed ID: 18465347
    [Abstract] [Full Text] [Related]

  • 12. Identification of a novel mutations BRCA1*c.80 + 3del4 and BRCA2*c.6589delA in Slovak HBOC families.
    Konecny M, Vizvaryova M, Zavodna K, Behulova R, Gerykova Bujalkova M, Krivulcik T, Cisarik F, Kausitz J, Weismanova E.
    Breast Cancer Res Treat; 2010 Jan 15; 119(1):233-7. PubMed ID: 19011960
    [Abstract] [Full Text] [Related]

  • 13. The prevalence of BRCA1 and BRCA2 germline mutations in high-risk breast cancer patients of Chinese Han nationality: two recurrent mutations were identified.
    Li WF, Hu Z, Rao NY, Song CG, Zhang B, Cao MZ, Su FX, Wang YS, He PQ, Di GH, Shen KW, Wu J, Lu JS, Luo JM, Liu XY, Zhou J, Wang L, Zhao L, Liu YB, Yuan WT, Yang L, Shen ZZ, Huang W, Shao ZM.
    Breast Cancer Res Treat; 2008 Jul 15; 110(1):99-109. PubMed ID: 17851763
    [Abstract] [Full Text] [Related]

  • 14. Screening for large rearrangements of the BRCA2 gene in Spanish families with breast/ovarian cancer.
    Gutiérrez-Enríquez S, de la Hoya M, Martínez-Bouzas C, Sanchez de Abajo A, Ramón y Cajal T, Llort G, Blanco I, Beristain E, Díaz-Rubio E, Alonso C, Tejada MI, Caldés T, Diez O.
    Breast Cancer Res Treat; 2007 May 15; 103(1):103-7. PubMed ID: 17063271
    [Abstract] [Full Text] [Related]

  • 15. A prospective study on predictive factors linked to the presence of BRCA1 and BRCA2 mutations in breast cancer patients.
    Wárlám-Rodenhuis CC, Koot VC, van der Luijt RB, Vasen HF, Ausems MG.
    Eur J Cancer; 2005 Jul 15; 41(10):1409-15. PubMed ID: 15955690
    [Abstract] [Full Text] [Related]

  • 16. Mutational analysis of BRCA1 and BRCA2 in Mediterranean Spanish women with early-onset breast cancer: identification of three novel pathogenic mutations.
    Martínez-Ferrandis JI, Vega A, Chirivella I, Marín-García P, Insa A, Lluch A, Carracedo A, Chaves FJ, García-Conde J, Cervantes A, Armengod ME.
    Hum Mutat; 2003 Nov 15; 22(5):417-8. PubMed ID: 14517958
    [Abstract] [Full Text] [Related]

  • 17. High proportion of BRCA1/2 founder mutations in Hispanic breast/ovarian cancer families from Colombia.
    Torres D, Rashid MU, Gil F, Umana A, Ramelli G, Robledo JF, Tawil M, Torregrosa L, Briceno I, Hamann U.
    Breast Cancer Res Treat; 2007 Jun 15; 103(2):225-32. PubMed ID: 17080309
    [Abstract] [Full Text] [Related]

  • 18. Screening for BRCA1 and BRCA2 mutations in Eastern Finnish breast/ovarian cancer families.
    Hartikainen JM, Kataja V, Pirskanen M, Arffman A, Ristonmaa U, Vahteristo P, Ryynänen M, Heinonen S, Kosma VM, Mannermaa A.
    Clin Genet; 2007 Oct 15; 72(4):311-20. PubMed ID: 17850627
    [Abstract] [Full Text] [Related]

  • 19. Incidence of BRCA1 and BRCA2 mutations in young Korean breast cancer patients.
    Choi DH, Lee MH, Bale AE, Carter D, Haffty BG.
    J Clin Oncol; 2004 May 01; 22(9):1638-45. PubMed ID: 15117986
    [Abstract] [Full Text] [Related]

  • 20. BRCA1 genetic testing in 106 breast and ovarian cancer families from Southern Italy (Sicily): a mutation analyses.
    Russo A, Calò V, Agnese V, Bruno L, Corsale S, Augello C, Gargano G, Barbera F, Cascio S, Intrivici C, Rinaldi G, Gulotta G, Macaluso M, Surmacz E, Giordano A, Gebbia N, Bazan V.
    Breast Cancer Res Treat; 2007 Nov 01; 105(3):267-76. PubMed ID: 17221156
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.